Mr Amol Dhamane
Bristol-Myers Squibb, Lawrenceville (United States of America)
Anticoagulant treatment patterns and thromboembolic events by tumor type among patients with VTE and cancer
Event: ESC Congress 2022
Topic: Venous Thromboembolism
Session: A journey through vascular diseases
Effectiveness, safety, and composite clinical outcomes between apixaban and other oral anticoagulants for non-valvular atrial fibrillation patients in the US Medicare population
Event: ESC Congress 2018
Topic: Oral Anticoagulation
Session: Atrial fibrillation - Stroke prevention 1
Effectiveness, safety, and composite clinical outcomes of apixaban, dabigatran, rivaroxaban, relative to warfarin in non-valvular atrial fibrillation patients in the US Medicare population
Event: ESC Congress 2018
Topic: Oral Anticoagulation
Session: Atrial fibrillation - Stroke prevention
ESC 365 is supported by
